Filing Details

Accession Number:
0001209191-23-030192
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-17 16:29:35
Reporting Period:
2023-05-15
Accepted Time:
2023-05-17 16:29:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA Pharmaceutical Preparations (2834) 113651945
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1903865 Samina Khan 5320 Legacy Drive
Plano TX 75024
Svp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-05-15 288 $85.32 39,843 No 4 S Direct
Class A Common Stock Disposition 2023-05-16 352 $81.37 39,491 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.